KetoSwiss develops products aimed at improving brain energetics, a common denominator in many neurological and psychiatric diseases. Its first flagship medical food for migraine, MigraKet by Brain Ritual, pairs ketone bodies with micronutrients essential for brain energy metabolism. MigraKet is clinically tested, patent-protected, and is planned to enter the U.S. market at the end of 2023. The company is led by CEO and Founder Dr. Elena Gross and is based in Basel, Switzerland. KetoSwiss raised $4.8M in the second closing of a Pre-Series A financing and will use the funds to expand R&D and clinical development efforts.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2023